(2026). Prolactin-Releasing Hormone Receptor (PRLHR) enhances radiosensitivity and exacerbates DNA damage in glioblastoma post-irradiation by inhibiting Y-box-binding protein-1 (YBX1) nuclear translocation: A novel perspective on precision radiotherapy. Molecular Biomedicine.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Prolactin-Releasing Hormone Receptor (PRLHR) Enhances Radiosensitivity and Exacerbates DNA Damage in Glioblastoma Post-irradiation by Inhibiting Y-box-binding Protein-1 (YBX1) Nuclear Translocation: A Novel Perspective on Precision Radiotherapy."
Molecular Biomedicine 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Prolactin-Releasing Hormone Receptor (PRLHR) Enhances Radiosensitivity and Exacerbates DNA Damage in Glioblastoma Post-irradiation by Inhibiting Y-box-binding Protein-1 (YBX1) Nuclear Translocation: A Novel Perspective on Precision Radiotherapy."
Molecular Biomedicine, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.